OS9 anticorps
-
- Antigène Voir toutes OS9 Anticorps
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp OS9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human OS9
- Isotype
- IgG
- Top Product
- Discover our top product OS9 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))
- Autre désignation
- OS9 (OS9 Produits)
- Synonymes
- anticorps OS-9, anticorps zgc:153838, anticorps 4632413K17Rik, anticorps AU022351, anticorps Os-9, anticorps ERLEC2, anticorps OS9, endoplasmic reticulum lectin, anticorps osteosarcoma amplified 9, endoplasmic reticulum lectin, anticorps amplified in osteosarcoma, anticorps OS9, anticorps os9, anticorps Os9
- Sujet
- This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
- Poids moléculaire
- 76 kDa
- UniProt
- Q13438
- Pathways
- Maintenance of Protein Location, SARS-CoV-2 Protein Interactome
-